Join Advamed on Tuesday, September 20 for this important and timely discussion on how the medtech industry can take action now to reduce health disparities and change patients lives.
Save the Date!
Medical technology can play a significant role in reducing health disparities, but patients must have access to the latest diagnostic and treatment tools to benefit. Health care providers and medical technology company experts will describe successes in the field in remote diabetes monitoring, cardiac and respiratory care, and diagnostics to help inform policymaking in this critical area. This free panel discussion will cover how the medtech industry can do its part to make a positive impact in closing health disparities. Register today to secure your spot!
Michael R. Crawford, MBA, MHL
Michael Crawford is the Associate Dean for Strategy, Outreach, and Innovation (ADSOI) at the Howard University College of Medicine and Founder and Executive Director of Howard University’s 1867 Health Innovations Project. Mr. Crawford serves as a strategic advisor to the Dean of Howard University College of Medicine and Vice President of Clinical Affairs and collaborates with medical science, health, academic, and HU Board leadership to advance Howard University’s academic, health, and innovation mission.
Mr. Crawford brings expertise at the intersection of operations, strategy, digital health, data, innovation, product development, and policy. A core focus of his work is related to developing scalable digital health models to enhance health access, outcomes, affordability, and patient experience. Mr. Crawford is a widely recognized strategic thinker, innovator, and problem solver, and sought-after speaker on topics related to digital health, data, health equity, and community engagement. Prior to Howard University, Mr. Crawford served as the Chief of Staff at Unity Health Care, Inc., one of the largest health center networks in the United States. Prior to Unity, Mr. Crawford held leadership positions at Johnson & Johnson, GlaxoSmithKline, Gannett Company, nonprofits, and start-ups. Over the past twenty years, Mr. Crawford has led complex organizational change management and transformation initiatives, along with cross functional teams to enhance organizational performance, productivity, products and programs, customer experience, and strategic partnerships.
Mr. Crawford serves on numerous national and local committees, including a Board Trustee of Cancer Research Institute, member of Robert Wood Johnson National Commission to Transform Public Health Data Systems, member of American Essential Hospitals Education Committee, member of the Advisory Board of National Minority Quality Forum, member of HIMSS Global Health Equity Network, member of the Academy of Health and Robert Wood Johnson Foundation Health Service Research Learning Community, and member of the District of Columbia Complete Count Committee.
Mr. Crawford holds a Master of Science in Healthcare Leadership (MHL) with a concentration in healthcare administration and management from Brown University, Master of Business Administration (MBA) with a concentration in strategic management and finance from The George Washington University, and a Bachelor of Science from Rider University with a concentration in Marketing Strategy.
Tony Ezell, MBA
Tony Ezell serves as the president of North America and chief marketing officer (CMO) for BD (Becton, Dickinson and Company), a leading global medical technology company headquartered in Franklin Lakes, New Jersey. In this role, he leads BD U.S. and Canada regions and the Global Marketing organization and is responsible for an integrated commercialization approach to how we prioritize and deliver on customer needs. He is also a member of the BD Executive Leadership Team.
Prior to BD, Ezell spent more than 27 years at Eli Lilly and Co., where he built a strong track record in sales, marketing and business leadership, having led global market research before assuming the role of chief customer officer. He went on to serve as chief marketing officer for Lilly’s Elanco Animal Health business prior to its spinoff and most recently led Lilly’s U.S. Connected Care and Insulins business as VP/GM.
Ezell has global operational experience, having lead organizations as large as 1,200. Additionally, he has a passion for people, as demonstrated by his history of building high performing teams and by his history of developing deep customer understanding and translating that understanding into meaningful brand campaigns. He is experienced in leading major transformation that spans business units, functions and geographies. He is a former member of the Board of Trustees for Brebeuf Jesuit High School, the Board of Directors for the Catholic Medical Mission Board and the KPMG Healthcare Advisory Board. He is also the former Chairman of the UNCF Indianapolis Leadership Council. He served on the Board of Directors for the Health Forum, Inc. from 2006 to 2012.
He has a degree in Business Administration from the School of Business and Industry (SBI) at Florida A & M University and an MBA from the Kellogg School of Management at Northwestern University.
Ramon L. Jimenez, M.D.
Dr. Ramon Jimenez was born and raised in San Jose California. After becoming an orthopedic surgeon in 1972, he founded and grew an orthopedic practice in San Jose. He has risen to the top of the orthopedic profession by achieving leadership roles in national, regional, and local healthcare provider organizations.
He developed a practice in medical-legal evaluations of industrial and personal injury patients after retiring from 40 years of a busy surgical practice that included mostly arthroscopy and reconstructive surgery of shoulders, hips and knees.
His service in the American Academy of Orthopedic Surgeons at many levels: Board of Directors, AAOS Leadership Fellows, patient and public education, physician-patient communication, Bone and Joint Decade, orthoinfo.org., speakers media bureau, advocacy, and DIVERSITY. His passion and commitment to “give back to orthopedics” is demonstrated in his persistent work with the AAOS. It culminated in his Presidency of Orthopedic Research and Education Foundation (2014-16). He also is past president of COA and WOA. In 2018, AAOS recognized and awarded him the prestigious AAOS Diversity Award in 2009 and the AAOS Bill Tipton Leadership Award in 2018.
Another passion of Dr. Jimenez is the diversity of the orthopaedic workforce, particularly aimed so that more Latino students choose orthopaedics as a life career. He was a founder and first president of the American Association of Latino Orthopaedic Surgeons (AALOS) whose primary purpose is mentoring young Latinos.
The issue of musculoskeletal disparities is a very complex one and he realizes that it must be met head on by all those who encounter it—patients, health care providers, hospitals, and even insurers. He has devoted the past fifteen years to working with other orthopedic leaders to reverse these disparities. He served on the Executive Steering Committee of Movement is Life (MIL) since its inception. He strongly and passionately believes in its goals- maintaining mobility to decrease the onset of arthritis, diabetes, obesity and associated co-morbidities–thereby, decreasing musculoskeletal disparate care in women, African-Americans and Hispanic/Latinos
Joaquin Cigarroa, M.D.
Dr. Joaquin Cigarroa is the Division Head of Cardiology and Clinical Chief of the Knight Cardiovascular Institute at Oregon Health & Science University in Portland, Oregon. He holds the endowed Melvin Judkins Professor of Cardiology and is a Professor of Medicine.
He works as an interventional cardiologist, with a specific focus on complex coronary interventions and structural heart disease. He has a longstanding interest in valvular heart disease, hypertrophic cardiomyopathy and performs procedures in all aspects of structural heart disease. Prior to joining OHSU he was the Director of Interventional Cardiology/Catheterization Laboratories at University of Texas Southwestern Medical School.
Dr. Cigarroa received a medical degree from Cornell University, New York, NY. He completed his residency in internal medicine and a fellowship in cardiovascular medicine and interventional cardiology from Massachusetts General Hospital, Boston, MA.
Dr. Cigarroa is currently the Chair of the FDA Circulatory Devices Panel, Chair of the DEI SCAI Committee, Co-chair of the Government Relations Committee and a committee member of the ACC Science and Quality Oversight Committee. He is Deputy Editor for CCI and serves on the editorial board for Circulation. He is an elected member of the Association of University Cardiologist and will be inducted into the American Clinical and Climatological Society this fall.
Carlos M. Nunez, M.D.
As the Chief Medical Officer at ResMed, Dr. Nunez leads Medical Affairs, Government Affairs, Market Access, Healthcare Economics, Digital Health Insights, and Clinical Development for the world’s leading provider of solutions for sleep and respiratory medicine, digital health, and post-acute care settings. This global, multidisciplinary team provides the professional and scientific expertise to align the clinical, economic and public policy realities of modern healthcare with the patient-centered mission and global business strategy of ResMed. This includes the safety, quality and regulatory efforts that touch every phase of the patient experience and product lifecycle, as well as the evidence generation and early-stage technology development that defines the cutting edge of clinical research, medical science, and advanced data analytics, including Artificial Intelligence and Machine Learning (AI/ML).
Dr. Nunez joined ResMed from Becton, Dickinson and Company (BD) where he was appointed Senior Vice President of Medical Affairs, and led the office of Science, Medicine and Technology for BD’s largest division, after a leading role in the integration efforts following the acquisition and merger of CareFusion, in one of the largest MedTech transactions in US history. Prior to that, Carlos was the Chief Medical Officer at CareFusion, where he built and led a global team that provided medical oversight for all the businesses and functions of the company. From 2000 to 2011 he was the Chief Physician Executive at Picis, Inc., an industry-leading medical informatics company, which became part of the Optum division of UnitedHealth Group. At Picis/Optum Carlos provided medical leadership as well as clinical direction for corporate strategy, marketing, product development, sales, implementation and customer relations for global markets.
Dr. Nunez received his Medical Doctor (M.D.) degree from the University of Miami School of Medicine; where he also completed postgraduate training in anesthesiology, critical care medicine and clinical research. Before beginning his career in the MedTech industry, Dr. Nunez was a practicing anesthesiologist, intensivist and hospitalist, director of critical care research, informatics and analytics, and the Duke University educational affiliation at Carolinas Medical Center Northeast.
Dr. Nunez is a globally recognized speaker on topics ranging from medical technology, digital health, data privacy and security, AI/ML, healthcare policy, and diversity and inclusion in healthcare. He has been an invited speaker at medical conferences, technology conferences, and the White House. He currently serves as vice-chair of the board of the Health Division, of the Consumer Technology Association, and will ascend to the chair position for a two-year term in January 2023. He also serves on the board of the ResMed foundation, and as a medical advisor for a sleep-related pharmaceutical company (Apnimed) and a sleep-focused venture capital company (Supermoon Capital).
This event will be held in Room 2168 (The Gold Room) of the Rayburn House Office Building on 45 Independence Ave SW, Washington, DC 20515. Lunch will be provided to attendees.
Hear From Us
Sign up to receive emails highlighting our upcoming events, early registration savings, and engagement opportunities for the medical technology community.